TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is prevalent worldwide. Despite its limitations, serum alpha-fetoprotein (AFP) remains the most widely-used biomarker for the diagnosis of HCC. This study aimed to assess whether measurement of peripheral plasma Dickkopf-1 (DKK1) and Tie...
Main Authors: | Liping Mao, Yueguo Wang, Delin Wang, Gang Han, Shouzhong Fu, Jianxin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5597119?pdf=render |
Similar Items
-
Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas
by: Ahmet Gurakar, et al.
Published: (2018-11-01) -
New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
by: Ting Wang, et al.
Published: (2020-08-01) -
Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
by: Xueying Wang, et al.
Published: (2020-01-01) -
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
by: Honglei Feng, et al.
Published: (2021-04-01) -
Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
by: Xi Zhang, et al.
Published: (2020-01-01)